Medtronic MDT
NYSE MDT
$92.42 +0.03 (+0.03%)
As of: Sep 9, 2026 · 12:13 PM EDT

Medtronic (MDT) Receivables - Other (2015 - 2016)

Medtronic's (MDT) quarterly Receivables - Other came in at $261.0 million in Q2 2016, down 11.82% year-over-year from $296.0 million in Q2 2015, and down 11.82% quarter-over-quarter from $296.0 million in Q2 2015.

Analysis

Medtronic (MDT) Receivables - Other (2015 - 2016) Analysis & Trends

Medtronic has disclosed Receivables - Other across 2 years of filings, most recently posting $261.0 million for Q2 2016.

  • In Q2 2016, Receivables - Other fell 11.82% year-over-year to $261.0 million; the TTM figure through Apr 2016 stood at $261.0 million (down 11.82% YoY), while the FY2016 annual figure was $261.0 million, down 11.82% from the prior year.
  • Receivables - Other came in at $261.0 million for Q2 2016 at Medtronic, down from $296.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $296.0 million in Q2 2015 to a low of $261.0 million in Q2 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 184.10 Bn 178.50 Bn 7.27 Bn
2 Intuitive Surgical 124.21 Bn 118.99 Bn 1.96 Bn
3 Medtronic 118.33 Bn 109.51 Bn 6.34 Bn
4 Stryker 104.21 Bn 100.73 Bn 4.50 Bn
5 Boston Scientific 66.39 Bn 65.86 Bn 3.85 Bn
6 Edwards Lifesciences 49.69 Bn 45.43 Bn 1.35 Bn
7 Alcon 33.94 Bn 32.48 Bn 1.68 Bn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn
9 Steris 21.15 Bn 20.67 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.14 Bn 17.73 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Apr 29, 2016 261.00 Mn
Apr 24, 2015 296.00 Mn